PubMed · 1983 · 62 citations · 9 references
Veterinary MedicineInfectious DiseasesVeterinary MicrobiologyEquine ScienceVaccinologyVirologyAnimal VirusesVaccinationVeterinary ImmunologyVeterinary VaccinesVeterinary VirologyViral VaccinesAnimal ImmunizationAntigenic TypingAntigenic Variation In VirusesEquine VirologyEquine VirusesVaccine FailuresVeterinary Vaccinology
Influenza outbreaks involving viruses of the H3N8 subtype (equine 2) often occur in vaccinated horses. For this reason, a series of influenza viruses of the H3N8 subtype were examined to determine if antigenic variation could be detected in isolates during the period 1963-81. Antigenic analyses with post-infection ferret sera and monoclonal antibodies showed that the haemagglutinins of recent isolates were antigenically distinguishable from the prototype A/eq/Miami/1/63 and that antigenically distinguishable groups of equine 2 viruses co-circulate in the horse population. Based on these studies, it is recommended that a recent equine strain, A/equine/Fontainebleu/1/79 or A/equine/Kentucky/1/81, serve as an additional prototype strain for this subtype.Antigenic variation in equine 2 viruses may be of epidemiological significance, yet the overall conservation of these strains makes it unlikely that vaccine failures can be attributed solely to antigenic changes in these viruses. A sufficiently potent vaccine, containing a current representative of the most prevalent equine 2 strain, may improve the protection afforded by equine vaccines.
9
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.
M Aymard-Henry, M. T. Coleman, W. R. Dowdle et al. · PubMed · 1973 · 421 citations
Robert G. Webster, W.G. Laver · Virology · 1980 · 264 citations
Walter Gerhard, R. G. Webster · The Journal of Experimental Medicine · 1978 · 159 citations · Full text